Intratracheal budesonide with surfactant cuts BPD at 36 weeks, but only when given within 4 hours
Mixing budesonide with surfactant may help infants with lung issues
This meta-analysis of 15 trials (3522 infants) examined intratracheal budesonide mixed with surfactant versus surfactant alone for bronchopu…
Mixing budesonide with surfactant may reduce lung disease in infants, but only if the treatment is given within four hours of birth.
Respiratory trajectories vary by gestational age in infants born before 26 weeks' gestation
New data tracks breathing progress for very premature infants
This post-hoc exploratory analysis of a randomized controlled trial involved 601 infants born before 26 weeks' gestation receiving surfactan…
A new look at clinical data helps doctors better predict and manage breathing needs for babies born before 26 weeks of pregnancy.
Multimodal lung-protective strategies reduce BPD risk in preterm infants
New insights into managing lung damage in preterm infants
This narrative review synthesizes evidence on bronchopulmonary dysplasia (BPD) in preterm infants, highlighting its multifactorial pathophys…
Doctors are identifying key risk factors and treatment paths for bronchopulmonary dysplasia to better protect the lungs of premature babies.
LISA and ENSURE show similar need for ventilation in preterm neonates with respiratory distress syndrome
Two Ways To Save Tiny Lungs Work Equally Well
An open-label, single-center RCT in 118 preterm neonates requiring surfactant therapy found no difference in need for invasive mechanical ve…
When a preemie's lungs fail, how doctors deliver the life-saving medicine may matter less than how carefully they follow the plan.